Brought to you by 
Supernus Pharmaceuticals' big Series A: $45mm
11 Apr 2007
Executive Summary
Supernus Pharmaceuticals, created last month when management bought out the assets of Shire PLC's drug formulation subsidiary Shire Laboratories, has raised $45mm in its Series A financing.
Deal Industry
- Biotechnology
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Controlled Release
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Supernus Pharmaceuticals' big Series A: $45mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice